A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis

Science

Volumn 323, Issue 5914, 2009, Pages 644-648

  Venteicher, Andrew S ^a   Abreu, Eladio B ^b   Meng, Zhaojing ^c   McCann, Kelly E ^a   Terns, Rebecca M ^b   Veenstra, Timothy D ^c   Terns, Michael P ^b   Artandi, Steven E ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b University of Georgia ^*  (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HOLOENZYME; RIBONUCLEOPROTEIN; TELOMERASE CAJAL BODY PROTEIN 1; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

CANCER; CHROMOSOME; ENZYME ACTIVITY; HOMINID; PROTEIN; RNA;

ARTICLE; CELLULAR DISTRIBUTION; COILED BODY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RNA INTERFERENCE; RNA SPLICING; TELOMERE;

AMINO ACID SEQUENCE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; COILED BODIES; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; RNA; RNA INTERFERENCE; TELOMERASE; TELOMERE;

EID: 59149095154     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1165357     Document Type: Article

References (24)

1. K. Collins, Nat. Rev. Mol. Cell Biol. 7, 484 (2006).
2. U. T. Meier, Chromosoma 114, 1 (2005).
3. A. G. Matera, R. M. Terns, M. P. Terns, Nat. Rev. Mol. Cell Biol. 8, 209 (2007).
4. J. R. Mitchell, E. Wood, K. Collins, Nature 402, 551 (1999).
5. Y. Mochizuki, J. He, S. Kulkarni, M. Bessler, P. J. Mason, Proc. Natl. Acad. Sci. U.S.A. 101, 10756 (2004).
6. S. B. Cohen et al., Science 315, 1850 (2007).
7. M. Kirwan, I. Dokal, Clin. Genet. 73, 103 (2008).
8. D. Fu, K. Collins, Mol. Cell 28, 773 (2007).
9. V. Pogacic, F. Dragon, W. Filipowicz, Mol. Cell. Biol. 20, 9028 (2000).
10. F. Dragon, V. Pogacic, W. Filipowicz, Mol. Cell. Biol. 20, 3037 (2000).
11. B. E. Snow et al., Curr. Biol. 13, 698 (2003).
12. P. Reichenbach et al., Curr. Biol. 13, 568 (2003).
13. G. Schnapp, H. P. Rodi, W. J. Rettig, A. Schnapp, K. Damm, Nucleic Acids Res. 26, 3311 (1998).
14. A. S. Venteicher, Z. Meng, P. J. Mason, T. D. Veenstra, S. E. Artandi, Cell 132, 945 (2008).
15. C. Hoareau-Aveilla, M. Bonoli, M. Caizergues-Ferrer, Y. Henry, RNA 12, 832 (2006).
16. U. T. Meier, G. Blobel, J. Cell Biol. 127, 1505 (1994).
17. B. E. Jady, E. Bertrand, T. Kiss, J. Cell Biol. 164, 647 (2004).
18. Y. Zhu, R. L. Tomlinson, A. A. Lukowiak, R. M. Terns, M. P. Terns, Mol. Biol. Cell 15, 81 (2004).
19. G. Cristofari et al., Mol. Cell 27, 882 (2007).
20. B. E. Jady, P. Richard, E. Bertrand, T. Kiss, Mol. Biol. Cell 17, 944 (2006).
21. R. L. Tomlinson, T. D. Ziegler, T. Supakorndej, R. M. Terns, M. P. Terns, Mol. Biol. Cell 17, 955 (2006).
22. F. Wang et al., Nature 445, 506 (2007).
23. H. Xin et al., Nature 445, 559 (2007).
24. This work was supported by Medical Scientist Training Program grant GM07365 (A.S.V.) and NCI grant CA104676 (M.P.T. and R.M.T.), with a Supplement to Promote Diversity in Health-Related Research (E.B.A.). This project has been funded in part with federal funds from the NCI under contract NO1-CO-12400 (T.D.V.). This work was supported by NCI grants CA111691 and CA125453 (S.E.A.) and by Leukemia and Lymphoma Society Specialized Centers of Research grant 7007-09 (S.E.A.).